The Cardiovascular Benefits Associated with the Use of Sodium-Glucose Cotransporter 2 Inhibitors - Real-World Data [0.03%]
钠葡萄糖协同转运蛋白2抑制剂的心血管益处——真实世界数据
Baptist Gallwitz
Baptist Gallwitz
Type 2 diabetes (T2D) is associated with numerous comorbidities that significantly reduce quality of life, increase mortality and complicate treatment decisions. In a recent cardiovascular outcomes trial, Empagliflozin Cardiovascular Outcom...
Sanjay Kalra,Rakesh Sahay
Sanjay Kalra
Fatigue is a common symptom in clinical medicine. The complex and multifaceted etiopathogenesis of fatigue is a challenge for the differential diagnosis and management of fatigue. This brief communication shares two simple mnemonics - LEMON...
The Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid Carcinoma [0.03%]
美国甲状腺协会2015年甲状腺结节和分化型甲状腺癌成人患者指南在最小化甲状腺癌过度诊断和治疗方面的重要性
Valeriano Leite
Valeriano Leite
The 2015 guidelines from the American Thyroid Association for adults with thyroid nodules and differentiated thyroid may be particularly important in minimising potential harm from overdiagnosis and overtreatment of thyroid tumours by provi...
Pier Paolo Bassareo,Angela Maria Zedda,Giuseppe Mercuro
Pier Paolo Bassareo
Arterial stiffness may be useful for stratifying cardiovascular risk in individuals suffering from a number of pathologies, such as hypertension, diabetes, obesity, dyslipidaemia and coronary artery disease. Cushing's syndrome is underpinne...
L H Duntas,Luca Chiovato
L H Duntas
Subclinical hypothyroidism (SCH) has been associated with increased cardiovascular mortality due to adverse effects mainly on lipids and blood pressure (BP). There is evidence that SCH, especially in patients with thyroid-stimulating hormon...
José Manuel Gómez Sáez
José Manuel Gómez Sáez
Primary hyperparathyroidism (PHPT) is a common cause of hypercalcaemia. The most common lesion found in patients is the solitary benign parathyroid adenoma. Multiple parathyroid adenomas have also been reported. Parathyroid carcinomas are a...
The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism [0.03%]
应用于一位原发性甲状旁腺功能亢进的九十多岁患者身上的Denosumab疗法
Tamer Shalaby,Samantha Anandappa,Siva Sivappriyan et al.
Tamer Shalaby et al.
Denosumab is a monoclonal antibody which is currently licensed in the UK drug market for the prevention of skeletal-related events secondary to malignancy (excluding myeloma). This monoclonal antibody is a 6 monthly subcutaneous injection t...
Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm [0.03%]
多靶点抑制剂在进展期和转移性甲状腺髓样癌治疗中的应用——新理念与挑战
Barbara Jarzab,Jolanta Krajewska
Barbara Jarzab
Medullary thyroid cancer (MTC) is an uncommon type of thyroid cancer, representing around 4 % of the all thyroid cancers, and is a challenging malignancy. So far, surgery has been the only curative treatment and until recently there have be...
Robin P Shook,Steven N Blair,John Duperly et al.
Robin P Shook et al.
The worldwide rise in body weight has reached epidemic proportions and this has serious public health consequences. Despite the universal recognition of this problem, its causes are still debated: some attribute it to excess caloric intake;...
Gregory A Hand,Steven N Blair
Gregory A Hand
In order to reverse the global obesity pandemic, there is a need for an enhanced understanding of the energy dynamics that underlie the problem. To maintain a stable body weight, energy intake must, over time, match or equal energy expendit...